Literature DB >> 15502677

Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.

Margaret R Weeks1, Katie E Mosack, Maryann Abbott, Laurie Novick Sylla, Barbara Valdes, Mary Prince.   

Abstract

OBJECTIVES: The objectives of this study were to measure microbicide acceptability among high-risk women in Hartford, Connecticut, and contextual factors likely to affect acceptability and use. GOAL: The goal of this study was to assess usefulness of microbicides for HIV/sexually transmitted infection (STI) prevention for high-risk women. STUDY: Ethnographic interviews (n = 75) and a survey (n = 471) explored women's perspectives on HIV/STI prevention, vaginal contraceptives similar to microbicides, and microbicide acceptability. Participants (n = 94) in a 2-week behavioral trial used an over-the-counter vaginal moisturizer to simulate microbicide use during sex with primary, casual, and/or paying partners.
RESULTS: Findings showed limited experience with vaginal contraceptives, but high interest in microbicides as an alternative to condoms, indicated by an acceptability index score of 2.73 (standard deviation, 0.49; scale of 1-4) in the overall sample. General microbicide acceptability varied by ethnicity, prior contraceptive and violence/abuse experiences, relationship power, and other attitudinal factors. The simulation trial indicated significant willingness to use the product in various locations and with all types of partners.
CONCLUSIONS: Vaginal microbicides may improve prevention outcomes for high-risk inner-city women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502677      PMCID: PMC1567977          DOI: 10.1097/01.olq.0000143113.04524.a5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  22 in total

1.  The need for microbicides: why aren't women's groups more involved in the fight against AIDS?

Authors:  M A Wainberg
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-20       Impact factor: 2.205

2.  Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS.

Authors:  E Hardy; K S de Pádua; M J Osis; A L Jiménez; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

3.  Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging.

Authors:  E Hardy; A L Jiménez; K S de Pádua; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

4.  Women's preferences for vaginal antimicrobial contraceptives. I. Methodology.

Authors:  E Hardy; K S de Pádua; A L Jiménez; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

5.  Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status.

Authors:  E Hardy; K S de Pádua; A L Jiménez; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

6.  Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.

Authors: 
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

7.  Streets, drugs, and the economy of sex in the age of AIDS.

Authors:  M R Weeks; M Grier; N Romero-Daza; M J Puglisi-Vasquez; M Singer
Journal:  Women Health       Date:  1998

Review 8.  Female-controlled methods to prevent sexual transmission of HIV.

Authors:  C J Elias; C Coggins
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

9.  Women's interest in vaginal microbicides.

Authors:  J E Darroch; J J Frost
Journal:  Fam Plann Perspect       Date:  1999 Jan-Feb

10.  Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  M Gross; S P Buchbinder; C Celum; P Heagerty; G R Seage
Journal:  Sex Transm Dis       Date:  1998-07       Impact factor: 2.830

View more
  28 in total

1.  Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Candelaria Barroso; Anna L Christensen; Cynthia Woodsong; Lawrence Severy
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

2.  Vaginal microbicide preferences among midwestern urban adolescent women.

Authors:  Amanda E Tanner; Jennifer M Katzenstein; Gregory D Zimet; Dena S Cox; Anthony D Cox; J Dennis Fortenberry
Journal:  J Adolesc Health       Date:  2008-06-05       Impact factor: 5.012

3.  Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Authors:  Lin Han; Fan Lv; Peng Xu; Guolei Zhang; Naomi S Juniper; Zhenglai Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

Review 4.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

5.  The promises and limitations of female-initiated methods of HIV/STI protection.

Authors:  Joanne E Mantell; Shari L Dworkin; Theresa M Exner; Susie Hoffman; Jenni A Smit; Ida Susser
Journal:  Soc Sci Med       Date:  2006-07-11       Impact factor: 4.634

6.  Intimate partner violence among HIV-infected crack cocaine users.

Authors:  Ameeta S Kalokhe; Anuradha Paranjape; Christine E Bell; Gabriel A Cardenas; Tamy Kuper; Lisa R Metsch; Carlos del Rio
Journal:  AIDS Patient Care STDS       Date:  2012-02-24       Impact factor: 5.078

7.  A little thing called love: condom use in high-risk primary heterosexual relationships.

Authors:  A Michelle Corbett; Julia Dickson-Gómez; Helena Hilario; Margaret R Weeks
Journal:  Perspect Sex Reprod Health       Date:  2009-12

8.  Predictors of using a microbicide-like product among adolescent girls.

Authors:  Mary B Short; Paul A Succop; Ana M Ugueto; Susan L Rosenthal
Journal:  J Adolesc Health       Date:  2007-07-20       Impact factor: 5.012

9.  High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.

Authors:  Katie E Mosack; Margaret R Weeks; Laurie Novick Sylla; Maryann Abbott
Journal:  Women Health       Date:  2005

10.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.